| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT06680921 A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in… |
Enrollment closed, study ongoing |
| 2026-08-12 | NCT06680921 A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in… |
Trial sites reduced: 60 -> 57 locations |
| 2026-08-12 | NCT06375044 Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma |
Primary endpoint(s) modified |
| 2026-08-12 | NCT06375044 Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma |
Trial sites expanded: 11 -> 14 locations |
| 2026-08-12 | NCT06375044 Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma |
date change Primary completion pushed: 2026-06-30 -> 2027-09-30 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-06 | NCT07749703 A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors | Phase 1 | Active, Not Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07361003 | A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory… | Refractory Metastatic Colorectal Cancer | Recruiting |
| NCT04914598 | A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary… | Malignant Pleural Effusion | Active, Not Recruiting |
| NCT06680921 | A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in… | Locally Advanced or Metastatic Breast Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT07175233 | A Phase 2 Study to Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to… | Atopic Dermatitis (AD) | Not Yet Recruiting |
| Phase 1 | |||
| NCT05528055 | A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With… | Solid Tumor | Recruiting |
| NCT06686745 | Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting |
| NCT06186414 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary… | Non-Muscle-Invasive Bladder Cancer (NMIBC) | Recruiting |
| NCT07007988 | A Phase I Study of SIM0388 in Participants With Malignant Ascites. | Malignant Ascites | Recruiting |
| NCT07050459 | A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors | Locally Advanced Solid Tumors | Recruiting |
| NCT07265921 | A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid… | Advanced Solid Cancer | Recruiting |
| NCT07357610 | An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin… | Healthy Adult Participants | Recruiting |
| NCT07348211 | First in Human Study of SIM0610 in Solid Tumors | Advanced Solid Tumours | Recruiting |
| NCT07345364 | A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety… | Health, Subjective | Recruiting |
| NCT07618260 | SIM0613 in Participants With Advanced Solid Tumors | Advanced Solid Cancer | Recruiting |
| NCT06375044 | Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma | Relapsed or Refractory Multiple Myeloma | Recruiting |
| NCT06654791 | Mass Balance Clinical Trial of SIM0270 | Healthy Participants | Active, Not Recruiting |
| NCT05293964 | Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced… | Breast Cancer | Active, Not Recruiting |
| NCT05718219 | Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0348 in… | Advanced Solid Tumors | Active, Not Recruiting |
| NCT07660432 | A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors | Neoplasms, Malignant | Not Yet Recruiting |
| NCT07749703 | A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors | Histologically or Cytologically Confirmed Advanced Solid Tumors | Active, Not Recruiting |